Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $848.7050 (-0.25%) ($848.7050 - $848.7050) on Tue. Dec. 19, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.14% (three month average) | RSI | 67 | Latest Price | $848.7050(-0.25%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.3% a day on average for past five trading days. | Weekly Trend | REGN advances 2.5% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) QQQ(89%) SDY(74%) IVE(67%) XLV(66%) XLF(65%) | Factors Impacting REGN price | REGN will decline at least -0.57% in a week (0% probabilities). VIXM(-59%) UNG(-31%) BNDX(-14%) VXX(-90%) USO(-22%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.57% (StdDev 1.14%) | Hourly BBV | -1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $861.27(-1.46%) | 10 Day Moving Average | $854.7(-0.7%) | 20 Day Moving Average | $832.9(1.9%) | To recent high | -3.2% | To recent low | 9.5% | Market Cap | $89.987b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |